Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 11,51 € (+42,98%). La mediana è 12,08 € (+50,06%).
| Acquista |
9 |
| Mantieni |
5 |
| Vendi |
3 |
Notizie Vai al feed delle notizie
Senseonics reports strong revenue growth and raises annual guidance despite high net loss
Senseonics posted Q1 2026 revenue up 85% to $11.7 million, an expanded gross margin of 58%, and raised its 2026 revenue outlook to $60–64 million. Net loss widened to $32.3 million, driven by higher commercialization and integration costs. Cash and cash equivalents stood at $64.6 million as of March 31; the company expects gross margins of 55–58% and plans operating expenses of $150–160 million. Management highlights growing acceptance of the Eversense 365 system but continues to see risks from high SG&A costs and intense competition in the CGM market. » Altro su de.investing.com
Senseonics expands credit facility with Hercules Capital to $140 million
Senseonics has completed a second amendment to its loan agreement with Hercules Capital, increasing the maximum credit line from $100 million to $140 million. The expansion includes near-term commitments of $20 million ( $10 million already drawn, $10 million expected on May 6) and up to $85 million in future tranches, with a final, undrawn $60 million tranche requiring investment committee approval. Including the two near-term tranches, borrowings under the agreement rise to about $55 million; as of March 31 Senseonics had cash and cash equivalents of roughly $64.6 million and expects, together with the new loans and net proceeds from a recent equity raise, to fund operations through 2028. » Altro su de.investing.com
Senseonics places $80m capital raise at $5.00 per share
Senseonics is offering 8,000,000 common shares at $5.00 per share and 8,000,000 pre-funded warrants at $4.999; gross proceeds expected to be about $80 million. The price is well below the current share price of $6.61. The proceeds are intended to finance the launch of Eversense 365, further pipeline development and general corporate purposes. The transaction is expected to close on May 4, 2026; TD Cowen and Barclays are acting as joint book-running managers. » Altro su de.investing.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 12,69 Mln | 124,96% |
| Utile lordo | 7,5 Mln | 183,22% |
| Utile netto | -32,16 Mln | 161,41% |
| EBITDA | -30,28 Mln | 174,83% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 336,56 Mln € |
Numero di azioni | 41,79 Mln |
Massimo/minimo a 52 settimane | 9,99 € - 4,13 € |
| Dividendi | No |
Beta | 0,97 |
Rapporto P/E | -4,11 |
Rapporto PEG | 0,39 |
Rapporto P/B | 5,98 |
Rapporto P/S | 8,03 |
Profilo aziendale
Senseonics Holdings, Inc. ist ein Medizintechnikunternehmen, das Systeme zur kontinuierlichen Glukoseüberwachung (CGM) für Menschen mit Diabetes in den Vereinigten Staaten, Europa, dem Nahen Osten und Afrika entwickelt und vertreibt. Zu den Produkten des Unternehmens gehören Eversense und Eversense XL, implantierbare CGM-Systeme zur Messung des Blutzuckerspiegels bei Diabetikern mittels eines unter der Haut befindlichen Sensors, eines abnehmbaren und wiederaufladbaren intelligenten Senders und einer praktischen App für die Echtzeitüberwachung und -verwaltung von Diabetes über einen Zeitraum von bis zu sechs Monaten. Das Unternehmen beliefert Gesundheitsdienstleister und Patienten über ein Netzwerk von Vertriebshändlern und strategischen Erfüllungspartnern. Das Unternehmen hat eine Kooperationsvereinbarung mit der University Hospitals Accountable Care Organization geschlossen. Senseonics Holdings, Inc. wurde 1996 gegründet und hat seinen Hauptsitz in Germantown, Maryland.
| Nome | Senseonics Holdings |
| CEO | Timothy T. Goodnow |
| Sede centrale | Germantown,
md Stati Uniti |
| Sito web | |
| Settore | Sanità |
| Industria | Attrezzature e forniture sanitarie |
| Quotazione in borsa | 22/12/2015 |
| Dipendenti | 130 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
AMEX | SENS |
Frankfurt | 6L6.F |
Düsseldorf | 6L6.DU |
München | 6L6.MU |
Scopri gli asset
Gli azionisti di Senseonics Holdings investono anche nei seguenti asset

